Harvard Pulmonary And Critical Care Medicine 2026
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
Target Audience: pulmonologists, intensivists, and critical care physicians, internists, hospital medicine physicians
The Harvard Pulmonary And Critical Care Medicine 2026 course provides a comprehensive, evidence-based review of the latest advancements in pulmonary, critical care, and sleep medicine. The program equips clinicians with cutting-edge strategies for diagnosing and managing complex respiratory conditions, intensive care emergencies, and emerging therapeutics to improve patient outcomes in both outpatient and ICU settings.
01 Breaking News in Pulmonary Medicine Dr. Benjamin Medof
02 Cystic Fibrosis Understanding CFTR and New Treatment Dr. Isabel Neuringer
03 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis Dr. Christopher Richards
04 Lung Transplantation 2026 Referral Patient Selection, Lung Allocation, and COVID Dr. Brian Keller
05 Exercise and Cardiopulmonary Disorders Indications and Interpretation Dr. C. Corey Hardin
06 Q&A with Speakers Drs. Isabel Neuringer, Christopher Richards, Brian Keller, and C. Corey Hardin
07 Pulmonary Pathology Interstitial Lung Disease Dr. Lida Hariri
08 Looking Deeper Patterns and Insights from Chest Radiology Dr. Amita Sharma
09 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD Dr. Barry Shea
10 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! Dr. Sydney Montesi
11 Treatment Challenges of Pulmonary Sarcoidosis Dr. Robert Hallowell
12 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs Dr. Grace Peloquin
13 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Barry Shea, Robert Hallowell, Grace Peloquin, and Sydney Montesi
14 Sedation, Analgesia, and Early Mobility The State ofthe Artin 2026 Dr. Crystal North
15 Noninvasive Respiratory Supportfor Acute Respiratory Failure Less May NOT Be Best Carolyn La Vita, MHA, RRT
16 Novel Ventilator Modes The Hype and Reality Carolyn La Vita, MHA, RRT
17 ARDS State-of-the-Art Strategies to Protectthe Lung Dr. Jehan Alladina
18 After the ICU Post-ICU Care Syndrome and Recovery Dr. George Alba
19 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Crystal North, George Alba, and Jehan Alladina, and Carolyn La Vita, MHA, RRT
20 From Ancient Egyptto Balanced Crystalloids Medicine’s Attempts to Manage Sepsis Dr. Eric Schmidt
21 Fluid Responsiveness Dr. David Ziehr
22 Vasopressors in Septic Shock Old Friends and New Dr. Jason Griffith
23 Approach to Empiric Antibiotics in the ICU Dr. Alyssa Letourneau
24 Approach to the Immunocompromised Critically Ill Patient Dr. Lisa Bebell
25 Renal Replacement Therapy in the ICU What and When to Start(or Not) Dr. Andrew Allegretti
26 Q&A with Speakers Drs. Kathryn Hibbert, Lisa Bebell, Alyssa Letourneau, David Ziehr, Eric Schmidt, Jason Griffith, and Andrew Allegretti
27 Common Neurologic Issues in the ICU Dr. Sahar Zafar
28 TTM and Neuro-prognostication After Cardiac Arrest Dr. David Greer
29 Surgical Emergencies in the Medical ICU Dr. Noelle Saillant
30 Updates in Management of Acute Pancreatitis Dr. Casey Luckhurst
31 Advanced Cardiac Supportin the ICU Dr. David Dudzinski
32 Q&A with Speakers Drs. Sahar Zafar, David Greer, Noelle Saillant, David Dudzinski, and Casey Luckhurst
33 Breaking Updates in Critical Care Dr. Kathryn Hibbert
34 Management ofthe Acutely Hemorrhaging Patient Dr. Raghu Chivkula
35 Point-of-Care Ultrasound in the Intensive Care Unit Dr. Jonah Rubin
36 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care Dr. Joshua Metlay
37 Prognosis and Uncertainty in the ICU Dr. Emily Rubin
38 Palliative Care in Advanced Lung Disease Dr. Jaclyn Shameklis
39 Q&A with Speakers Drs. Kathryn Hibbert, Emily Rubin, Joshua Metlay, Jaclyn Shameklis, and Jonah Rubin
40 Pleural Disease 2026 Updates Dr. Fayez Kheir
41 Interventional Pulmonology in 2026 Dr. Colleen Keyes
42 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond Dr. Colleen Keyes
43 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies Dr. Allison Chang
44 COPD 2026 Dr. Walter O’Donnell
45 Q&A with Speakers Drs. Angela Frank, Fayez Kheir, Colleen Keyes, and Walter O’Donnell
46 Aspergillus Lung Disease Dr. Rod Rahimi
47 Asthma What’s New in 2026 Dr. Miranda Theodore
48 New Therapeutics in Lung Disease The Age of Immunotherapy Dr. Benjamin Medof
49 A Strategic Approach to the Management of Pulmonary Nodules Dr. Angela Frank
50 Tuberculosis in 2026 Dr. Jodian Pinkney
51 Nontuberculous Mycobacterial Disease Navigating the Labyrinth Dr. Rocio Hurtado
52 Q&A with Speakers Drs. Kathryn Hibbert, Benjamin Medof, Rocio Hurtado, Angela Frank, Rod Rahimi, and Jodian Pinkney
53 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fitin 2026 Dr. Rachel Rosovsky
54 Pulmonary Embolism An Update Dr. Alison Witkin
55 Pulmonary Hypertension Categorization and Evaluation Dr. Josanna Rodriguez-Lopez
56 Pulmonary Hypertension Management Dr. Alexandra Wong
57 Vasculitis and ANCA Dr. Rachel Knipe
58 Q & A with Speakers Drs. Alison Witkin, Josanna Rodriguez-Lopez, Alexandra Wong, Angela Frank, and Rachel Rosovsky
59 Obstructive Sleep Apnea Dr. James Mojica
60 Central Sleep Apnea 2026 Dr. James Mojica
61 Sleep Diagnostics Dr. Katherine Dudley
62 Noninvasive Ventilation Dr. Katherine Dudley
63 Q & A with Speakers Drs. James Mojica and Katherine Dudley

The 4th Annual NYU Langone Critical Care Cardiology Symposium 2024 




